Trinity Innovation Bioventure Singapore

Trinity Innovation Bioventure Singapore is a venture capital firm established in 2018 and located in Singapore. The firm focuses on investing in early-stage biotechnology startups, aiming to support innovative companies within the biotech sector. By targeting nascent ventures, Trinity Innovation Bioventure seeks to foster advancements in biotechnology and contribute to the growth of the industry.

Thomas Keller Ph.D

Investment Partner

Langdon Wu

Managing Director

Taoqi Huangfu Ph.D

Partner and Managing Director

Jack Zheng Ph.D

Founder and Partner

David Wang Xukun Ph.D

Partner

1 past transactions

Axcynsis Therapeutics

Seed Round in 2022
Tetris Therapeutics is a platform-based biotechnology company focusing on the development of antibody drug conjugate (ADC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of ADC candidates with the potential to address unmet medical needs for new treatment options.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.